{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:44:38Z","timestamp":1759333478551},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.biologicals.2004.10.004","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T08:49:10Z","timestamp":1106988550000},"page":"41-48","source":"Crossref","is-referenced-by-count":6,"title":["Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivatives"],"prefix":"10.1016","volume":"33","author":[{"given":"Christoph","family":"Buchta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Macher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"H\u00f6cker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2004.10.004_bib1","series-title":"Applied blood group serology","author":"Issitt","year":"1998"},{"key":"10.1016\/j.biologicals.2004.10.004_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1537-2995.2000.40050551.x","article-title":"Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin","volume":"40","author":"Rushin","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2141.1969.tb00382.x","article-title":"Serum blood group substances and AB0 hemolytic disease","volume":"16","author":"Denborough","year":"1969","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biologicals.2004.10.004_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2141.1974.tb06650.x","article-title":"The radioimmunoassay of serum and salivary blood group A and Lea glycoproteins","volume":"28","author":"Holburn","year":"1974","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biologicals.2004.10.004_bib5","series-title":"Blood transfusion in clinical medicine","author":"Mollison","year":"1987"},{"key":"10.1016\/j.biologicals.2004.10.004_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-89-4-515","article-title":"Anti-A hemolytic transfusion with packed 0 cells","volume":"89","author":"Inwood","year":"1978","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.biologicals.2004.10.004_bib7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jcp.33.10.954","article-title":"Anti-A haemagglutinins in factor VIII concentrates","volume":"33","author":"Smith","year":"1980","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.biologicals.2004.10.004_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-3476(76)80937-7","article-title":"Comparison of anti-A and anti-B titers in factor VIII and IX concentrates","volume":"89","author":"Seeler","year":"1976","journal-title":"J Pediatr"},{"key":"10.1016\/j.biologicals.2004.10.004_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1537-2995.1970.tb00721.x","article-title":"Hemolytic anemia due to anti-A in concentrated antihemophilic factor preparations","volume":"10","author":"Rosati","year":"1970","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0140-6736(75)90104-X","article-title":"Factor VIII concentrate in hemophilia","volume":"2","author":"Tamagnini","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2004.10.004_bib11","first-page":"100","article-title":"Anti-A in factor VIII concentrate: a cause of severe hemolysis in a patient with acquired factor VIII:C antibodies","volume":"16","author":"Hach-Wunderle","year":"1989","journal-title":"Infusionstherapie"},{"issue":"1","key":"10.1016\/j.biologicals.2004.10.004_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.1972.03650010087016","article-title":"Hemolysis due to anti-A and anti-B in factor VIII preparations","volume":"130","author":"Seeler","year":"1972","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.biologicals.2004.10.004_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000207840","article-title":"Hemophiliac with hemolytic anemia resulting from factor VIII concentrate","volume":"58","author":"Soni","year":"1977","journal-title":"Acta Haematol"},{"issue":"9","key":"10.1016\/j.biologicals.2004.10.004_bib14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archinte.1976.03630090048011","article-title":"Hemolysis caused by factor VIII concentrates","volume":"136","author":"Orringer","year":"1976","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.biologicals.2004.10.004_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.2830180302","article-title":"Changes in plasma haptoglobin and alpha-2-macroglobulin in hemophiliacs receiving factor replacement therapy","volume":"18","author":"Shulman","year":"1985","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.biologicals.2004.10.004_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0038-1653409","article-title":"High frequency of low plasma haptoglobin values found in hemophilia A patients on prophylactic treatment with factor VIII concentrates \u2013 a sign of hemolysis?","volume":"46","author":"Egberg","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.biologicals.2004.10.004_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1537-2995.1987.27387235645.x","article-title":"Immune hemolysis by isohemagglutinins in factor IX concentrates","volume":"27","author":"Ragni","year":"1987","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1537-2995.1987.27187121468.x","article-title":"Positive antiglobulin tests due to intravenous immunoglobulin in patients who received bone marrow transplant","volume":"27","author":"Robertson","year":"1987","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1537-2995.1971.tb04433.x","article-title":"Red blood cell sensitization due to unexpected Rh antibodies in immune serum globulin","volume":"11","author":"Obermann","year":"1971","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib20","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM197112162852516","article-title":"Blood group antibodies in human immune serum globulin","volume":"285","author":"Niosi","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2004.10.004_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ajcp\/60.2.205","article-title":"Immune serum globulin: a cause for anti-Rh0(D) passive sensitization","volume":"60","author":"Lang","year":"1973","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.biologicals.2004.10.004_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1537-2995.1980.20180125049.x","article-title":"Levels of anti-A and anti-B in commercial immune globulins","volume":"20","author":"Gordon","year":"1980","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9343(87)90112-4","article-title":"Hemolytic anemia following intravenous gamma globulin administration","volume":"82","author":"Brox","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.biologicals.2004.10.004_bib24","first-page":"114","article-title":"Hemolytic anemia following intravenous gamma globulin administration","volume":"93","author":"Brox","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.biologicals.2004.10.004_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0140-6736(83)90175-7","article-title":"Effect of intravenous immunoglobulin in immune thrombocytopenia","volume":"ii","author":"Salama","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2004.10.004_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1537-2995.1986.26587020113.x","article-title":"Hemolysis following intravenous immune globulin therapy","volume":"26","author":"Copelan","year":"1996","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.biologicals.2004.10.004_bib27","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/(SICI)1097-4598(199709)20:9<1142::AID-MUS8>3.0.CO;2-8","article-title":"Hemolytic anemia associated with intravenous immunoglobulin","volume":"20","author":"Wilson","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.biologicals.2004.10.004_bib28","first-page":"200","article-title":"Demonstration of isoagglutinins in intravenously applicable immunoglobulin preparations","volume":"32","author":"Strobel","year":"1994","journal-title":"Beitr Infusionsther Transfusionsmed"},{"key":"10.1016\/j.biologicals.2004.10.004_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00043426-198821000-00012","article-title":"Massive intravascular hemolysis associated with intravenous immunoglobulin in bone marrow transplant recipients","volume":"10","author":"Kim","year":"1988","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.biologicals.2004.10.004_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1096-8652(200003)63:3<160::AID-AJH11>3.0.CO;2-4","article-title":"Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease","volume":"63","author":"Nakagawa","year":"2000","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.biologicals.2004.10.004_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00002826-199710000-00002","article-title":"Side effects of high-dose intravenous immunoglobulins","volume":"20","author":"Stangel","year":"1997","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"10.1016\/j.biologicals.2004.10.004_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000056085","article-title":"Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases","volume":"62","author":"Sherer","year":"2001","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.biologicals.2004.10.004_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2165\/00002018-199309040-00003","article-title":"Adverse effects of intravenous immunoglobulin","volume":"9","author":"Misbah","year":"1993","journal-title":"Drug Saf"},{"key":"10.1016\/j.biologicals.2004.10.004_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJM199107113250207","article-title":"The use of intravenous immune globulin in immunodeficiency diseases","volume":"325","author":"Buckley","year":"1991","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.biologicals.2004.10.004_bib35","first-page":"79","article-title":"Side effects of intravenous immune globulins","volume":"97","author":"Duhem","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.biologicals.2004.10.004_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000206033","article-title":"Hemolysis due to high-dose intravenous gammaglobulin treatment for patients with idiopathic thrombocytopenic purpura","volume":"76","author":"Nakamura","year":"1986","journal-title":"Acta Haematol"},{"issue":"5","key":"10.1016\/j.biologicals.2004.10.004_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7883\/yoken1952.34.271","article-title":"AB0 blood group activities in human albumin preparations","volume":"34","author":"Yasuda","year":"1981","journal-title":"Jpn J Med Sci Biol"},{"key":"10.1016\/j.biologicals.2004.10.004_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.1977.03270310039005","article-title":"Albumin. 1. Background and use","volume":"237","author":"Tullis","year":"1977","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biologicals.2004.10.004_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1537-2995.1976.16176130834.x","article-title":"The use of pluronic polyols in the precipitation of plasma proteins and its application in the preparation of plasma derivatives","volume":"16","author":"Garcia","year":"1976","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib40","unstructured":"European Directorate for the Quality of Medicines. European Pharmacopoeia, 4th ed., 2002, Method 2.6.20."},{"key":"10.1016\/j.biologicals.2004.10.004_bib41","unstructured":"European Directorate for the Quality of Medicines. European Pharmacopoeia, 2nd ed., 1986, Method VIII.12."},{"key":"10.1016\/j.biologicals.2004.10.004_bib42","unstructured":"USP XXI, General information, (1041) Biologics, 1985 p. 1285."},{"key":"10.1016\/j.biologicals.2004.10.004_bib44","unstructured":"Association of Biologicals Manufacturers of Japan: Minimum Requirements for Biological Products; Ministry of Health and Welfare, Association of Biologicals Manufacturers of Japan, Tokyo; 1993."},{"key":"10.1016\/j.biologicals.2004.10.004_bib45","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2141.1964.tb00698.x","article-title":"The plasma concentration of Factor VIII in the normal population. II. The effects of age, sex and blood group","volume":"10","author":"Preston","year":"1964","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biologicals.2004.10.004_bib46","series-title":"Immunobiology of Transfusion Medicine","first-page":"201","article-title":"Do blood groups have a biological role?","author":"Garratty","year":"1994"},{"key":"10.1016\/j.biologicals.2004.10.004_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.1979.tb00398.x","article-title":"Factor VIII concentrate prepared from DDAVP stimulated blood donor plasma","volume":"22","author":"Nilsson","year":"1979","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.biologicals.2004.10.004_bib48","first-page":"19","article-title":"Desmopressin (DDAVP) for treatment of disorders of hemostasis","volume":"8","author":"Mannucci","year":"1986","journal-title":"Prog Hemostas Thromb"},{"key":"10.1016\/j.biologicals.2004.10.004_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1537-2995.1982.22382224947.x","article-title":"Factor VIII concentrate prepared from blood doors stimulated with intranasal DDAVP","volume":"22","author":"Mikaelsson","year":"1982","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.biologicals.2004.10.004_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jca.2920070208","article-title":"Donor reactions during DDAVP-stimulated plasmapheresis","volume":"7","author":"Randels","year":"1992","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.biologicals.2004.10.004_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2516.2000.00367.x","article-title":"Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients","volume":"6","author":"Dunn","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.biologicals.2004.10.004_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1537-2995.1976.16176130837.x","article-title":"Genetics of anti-A and anti-B levels","volume":"16","author":"Grundbacher","year":"1976","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.biologicals.2004.10.004_bib53","first-page":"317","article-title":"Quantity of haemolytic anti-A and anti-B in individuals of a human population: correlations with isoagglutinins and effects of the individual's age and sex","volume":"134","author":"Grundbacher","year":"1967","journal-title":"Z Immunitatsforsch Allerg Klin Immunol"},{"key":"10.1016\/j.biologicals.2004.10.004_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1423-0410.1971.tb00561.x","article-title":"Universality of anti-A and anti-B human isolysins","volume":"21","author":"Daufi","year":"1971","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2004.10.004_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)06318-1","article-title":"Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus and HIV-1 in a blood bank setting","volume":"353","author":"Roth","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biologicals.2004.10.004_bib56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1537-2995.2001.41060845.x","article-title":"Reducing the residual risk of transfusion-transmitted viruses: mini-pool or single-donation NAT?","volume":"41","author":"Roth","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib57","unstructured":"Dr. Rudolf Worofka, Baxter BioScience, Vienna, Austria, Personal communication January 16th, 2003."},{"key":"10.1016\/j.biologicals.2004.10.004_bib58","first-page":"546","article-title":"Blood compatible coating of synthetic immunoadsorbents","volume":"26","author":"Chang","year":"1980","journal-title":"Trans Am Soc Artif Intern Organs"},{"issue":"6","key":"10.1016\/j.biologicals.2004.10.004_bib59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1423-0410.1985.tb00196.x","article-title":"Whole blood immunoadsorption of anti-A or anti-B antibodies","volume":"48","author":"Bensinger","year":"1985","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2004.10.004_bib60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJM198101153040308","article-title":"Immunoadsorption for removal of A and B blood group substances","volume":"304","author":"Bensinger","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2004.10.004_bib61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1537-2995.1981.21381201809.x","article-title":"In vitro and in vivo removal of anti-A erythrocyte antibody by adsorption to a synthetic immunoadsorbent","volume":"21","author":"Bensinger","year":"1981","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.biologicals.2004.10.004_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jab.770030103","article-title":"An improved affinity support and immunoadsorbent with a synthetic blood group oligosaccharide and a polymer coating for hemoperfusion","volume":"3","author":"Mazid","year":"1992","journal-title":"J Appl Biomater"},{"key":"10.1016\/j.biologicals.2004.10.004_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1423-0410.1993.tb02129.x","article-title":"Improved removal of anti-A and anti-B antibodies from plasma using blood-group-active haptens","volume":"65","author":"Blomberg","year":"1993","journal-title":"Vox Sang"},{"issue":"6","key":"10.1016\/j.biologicals.2004.10.004_bib64","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00002480-200011000-00010","article-title":"Specific removal of anti-A and anti-B antibodies by using modified dialysis filters","volume":"46","author":"Hout","year":"2000","journal-title":"ASAIO J"},{"key":"10.1016\/j.biologicals.2004.10.004_bib65","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1046\/j.1537-2995.2000.40101207.x","article-title":"Transfusion errors in New York State: an analysis of 10 year's experience","volume":"40","author":"Linden","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1423-0410.1994.tb00292.x","article-title":"Bedside transfusion errors. A prospective study by the Belgium SAnGUIS Group","volume":"66","author":"Baele","year":"1994","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2004.10.004_bib67","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2141.2000.01876.x","article-title":"Comparing near misses with actual mistransfusion events: a more accurate reflection of transfusion errors","volume":"108","author":"Ibojie","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biologicals.2004.10.004_bib68","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1046\/j.1537-2995.2002.00230.x","article-title":"The risk of transfusion to the wrong patient in Germany","volume":"42","author":"Caspari","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.10.004_bib69","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood.V82.12.3789.3789","article-title":"Hemolysis after high-dose intravenous Ig","volume":"82","author":"Thomas","year":"1993","journal-title":"Blood"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105604000843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105604000843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T13:33:00Z","timestamp":1586093580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105604000843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S1045105604000843"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2004.10.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}